Clinical Trial

An Observational Study of Patients With Dermatologic Disease

Study acronym: TARGET-DERM+
Recruiting
View on ClinicalTrials.gov →
Summary
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Trial Details
NCT Number NCT07748169
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Vitiligo, Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa (HS)
Enrollment 2,000,000 participants
Start Date 2026-08-01
Primary Completion 2041-08-03 (estimated)
Study Completion 2041-08-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-05